Literature DB >> 31004202

Locally advanced rectal cancer: qualitative and quantitative evaluation of diffusion-weighted magnetic resonance imaging in restaging after neoadjuvant chemo-radiotherapy.

Maria Napoletano1, Daniele Mazzucca2, Enrico Prosperi3, Maria Cristina Aisa4, Marco Lupattelli5, Cynthia Aristei5, Michele Scialpi2.   

Abstract

PURPOSE: To determine the added value of qualitative and quantitative evaluation of diffusion-weighted magnetic resonance imaging (DWI) in locally advanced rectal cancer (LARC) restaging after neoadjuvant chemo-radiotherapy (CRT).
MATERIALS AND METHODS: A retrospective study was performed of 21 patients with LARC treated with CRT. All patients were evaluated with 1.5 T conventional magnetic resonance imaging (MRI) and DWI (0-1000 s/mm²) before starting therapy and after neoadjuvant CRT. All included patients underwent surgery after CRT: the histopathological evaluation of surgical specimens represented the reference standard for local staging after neoadjuvant therapy. The qualitative analysis was carried out by two operators in consensus, who reviewed the conventional MR image set [T1-weighted and T2-weighted morphological sequences + dynamic contrast-enhanced sequences (DCE)] and the combined set of conventional and DW images. For the quantitative analysis, the apparent diffusion coefficient (ADC) values were measured at each examination. For each lesion, the mean ADC value (ADCpre and ADCpost) and the ΔADC (ADCpost - ADCpre) were calculated, and values of the three groups of response [complete response (pCR), partial response (pPR), stable disease (pSD)] were compared.
RESULTS: In LARC restaging, conventional MRI showed a sensitivity of 80% and a specificity of 50%, with a total diagnostic capacity of 71.40%, while by adding DWI sensitivity increased to 100%, specificity to 67%, and total diagnostic capacity to 90.40%. ΔADC correlates with treatment response and a cutoff of 1.35 × 10-3 mm²/s predicts the pCR with a sensitivity of 93.3% and a specificity of 83.3%.
CONCLUSIONS: Adding DWI to conventional sequences may improve MRI capability to evaluate tumor response to CRT. The quantitative DWI assessment is promising, but larger studies are required.

Entities:  

Keywords:  Chemo-radiotherapy; DWI; LARC

Year:  2019        PMID: 31004202     DOI: 10.1007/s00261-019-02012-4

Source DB:  PubMed          Journal:  Abdom Radiol (NY)


  4 in total

1.  Diagnostic accuracy of b800 and b1500 DWI-MRI of the pelvis to detect residual rectal adenocarcinoma: a multi-reader study.

Authors:  David D B Bates; Jennifer S Golia Pernicka; James L Fuqua; Viktoriya Paroder; Iva Petkovska; Junting Zheng; Marinela Capanu; Juliana Schilsky; Marc J Gollub
Journal:  Abdom Radiol (NY)       Date:  2020-02

Review 2.  Comparison of percentage changes in quantitative diffusion parameters for assessing pathological complete response to neoadjuvant therapy in locally advanced rectal cancer: a meta-analysis.

Authors:  Kai Chen; Hua-Long She; Tao Wu; Fang Hu; Tao Li; Liang-Ping Luo
Journal:  Abdom Radiol (NY)       Date:  2020-09-25

3.  Prognostic implications of mucinous histology in stage III colon cancer with the receipt of adjuvant chemotherapy.

Authors:  Feng Yu; Luqiao Huang; Feng Shen; Shuang Wu; Jian Chen
Journal:  J Gastrointest Oncol       Date:  2020-10

4.  Diffusion weighted imaging improves diagnostic ability of MRI for determining complete response to neoadjuvant therapy in locally advanced rectal cancer.

Authors:  Anuradha Chandramohan; Umar M Siddiqi; Rohin Mittal; Anu Eapen; Mark R Jesudason; Thomas S Ram; Ashish Singh; Dipti Masih
Journal:  Eur J Radiol Open       Date:  2020-02-25
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.